All Articles

In a complex financial market, one firm's new L&D chief isn't just a hire; it's a strategic weapon. Here's why their investment in talent could pay dividends.

A groundbreaking Miami Art Week event unites fashion, poetry, and design to redefine Indian creativity, moving beyond stereotypes to forge a new legacy.

A new fintech and education alliance aims to arm underserved founders with capital and skills, potentially unlocking the next wave of healthcare innovation.

Sachem Capital's dividend announcement reveals a ~19% yield. We dissect the strategy of this mortgage REIT and its role as a disruptor in private lending.

With a clear FDA path for its breakthrough drug, Praxis is set to disrupt the stagnant, multi-billion-dollar essential tremor market.

Beyond marble floors, the new luxury is a seamless, secure, and AI-driven transaction. We explore how tech is reshaping high-end property deals.

A Nasdaq firm is using AI real estate software profits to build a massive Solana treasury. Capital Currents unpacks DFDV's radical dual-pronged strategy.

Baxter is buying back billions in debt, a strategic move to clean its balance sheet. But with operational issues mounting, is it enough to win back investors?

After its DMD drug trial sent shares soaring over 370%, Capricor Therapeutics is raising $75M. A look at the high-stakes strategy to fund a breakthrough.

A new partnership seeks to launch a 50-branch roofing giant in one year, betting on a single software platform to conquer a fragmented, low-tech industry.

Immunome is using strategic stock grants to lure top talent. We analyze why this move is critical for its pipeline and what it means for investors.

A new Kroger in Fate, TX signals more than retail growth; it's a blueprint for how food access, health services, and market strategy are shaping boomtowns.

With its CFO departing after a major strategic pivot, AAR CORP. names a 13-year insider as his interim replacement. What does this signal for investors?

Virax secured a $5M runway for its Long COVID diagnostics, but the deal's terms reveal a high-stakes gamble involving significant shareholder dilution.

At-home dental tech is booming. Discover how companies are using UVC sterilizers and advanced formulas to disrupt the traditional oral care industry.

Tigerlily Foundation and Bristol Myers Squibb are using brunch to address dire racial disparities in clinical trials. Is this the future of health equity?

With $15M in new funding and seasoned mining execs on board, Getty Copper is now debt-free and poised to unlock the potential of its vast copper assets.

Promising Phase 3 data reveals a novel, organ-sparing laser therapy for a rare cancer, signaling a potential paradigm shift away from radical surgery.

Bitwise appoints a new data VP amid a frenzied AI market. But can one leader bridge the gap between massive spending and measurable business results?

Beyond the hype of air taxis, one Oregon firm is electrifying aviation's workhorses, from firefighting helicopters to military vehicles, in extreme conditions.